Setmelanotide
Setmelanotide (brand name Imcivree) is an FDA-approved injectable peptide that switches on a brain receptor controlling hunger. It is approved specifically for rare forms of severe obesity driven by the brain hunger pathway, not for general weight loss, and in trials it cut both hunger and body weight in those conditions.
Verified sources for Setmelanotide
These vendors are vetted by PeptideWiki for purity testing and COA transparency.
Overview of Setmelanotide
A once-daily injection that turns on a brain switch called MC4R, restoring the fullness signal that is missing in certain rare genetic forms of obesity.
The body manages appetite through the leptin-melanocortin pathway. A key switch in that pathway is the MC4R receptor in the brain, which signals fullness.
In people with certain rare genetic defects (in the POMC, PCSK1, or LEPR genes, or Bardet-Biedl syndrome), the natural signal that activates MC4R is missing or weak, causing relentless hunger and severe early-onset obesity.
Setmelanotide is a lab-made peptide that activates MC4R directly, more strongly than the body's own signal, restoring the fullness signal so hunger and body weight fall.
It was designed for, and approved for, people whose obesity is driven by a broken melanocortin pathway. The trials enrolled these specific genetic groups, where it worked well.
It has not been approved or shown to produce the same results in the general population, where the pathway is usually intact.
In the genetic-deficiency trials, the majority of participants lost meaningful body weight over a year, alongside large drops in hunger scores.
A common and expected effect is darkening of skin and moles, because the same receptor family influences skin pigment.
Read Full Setmelanotide Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Metabolic & Weight Loss